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Background: The present article has been written to convey con-
cepts of anaesthetic care within the context of an Enhanced
Recovery After Surgery (ERAS) programme, thus aligning the
practice of anaesthesia with the care delivered by the surgical
team before, during and after surgery.
Methods: The physiological principles supporting the imple-
mentation of the ERAS programmes in patients undergoing major
abdominal procedures are reviewed using an updated literature
search and discussed by a multidisciplinary group composed of
anaesthesiologists and surgeons with the aim to improve periop-
erative care.
Results: The pathophysiology of some key perioperative ele-
ments disturbing the homoeostatic mechanisms such as insulin
resistance, ileus and pain is here discussed.
Conclusions: Evidence-based strategies aimed at controlling the
disruption of homoeostasis need to be evaluated in the context of
ERAS programmes. Anaesthesiologists could, therefore, play a
crucial role in facilitating the recovery process.
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REVIEW ARTICLE
Editorial comment: what this article tells us
Complications after surgery are still a major problem. Enhanced Recovery after Surgery (ERAS)
programmes may minimise some of the negative impact of surgery on organ function and this arti-
cle describes the pathophysiology and the role of the anaesthesiologist in this context.
Despite steady advances in anaesthetic and sur-
gical techniques over the years, post-operative
complications remain one of the major draw-
backs of surgery, not only for the specific
patient involved but also for their surgical care
team and the health care system in general.
Rarely do patients die on the operating table
during the surgical procedure, but rather from
the pathophysiological response to surgery and
its complications. The progressive understand-
ing of the physiological basis of surgical injury
has been the rationale underpinning the
research efforts of interdisciplinary teams, incor-
porating surgeons, anaesthesiologists and
nurses (among others) to minimise the surgical
stress response and thereby improve outcomes.
However, one of the immediate challenges to
improve the quality of perioperative care is not
to discover new knowledge, but rather to inte-
grate what we already know into clinical prac-
tice. To this end, the concept of “fast-track
surgery” was introduced in the 1990s by Henrik
Kehlet. It was demonstrated that by applying
evidence-based perioperative principles to open
colonic surgery, the post-operative length of
hospital stay could be reduced to 2–3 days.1,2
Realising that the surgical journey involves
many professional competencies, a more inte-
grated, multiprofessional, multidisciplinary
approach was needed, whereby a decision
taken early in the course of the treatment plan
would impact on later developments and influ-
ence the choices available for recovery further
down the line. Unfortunately, large gaps still
exist between what the evidence suggests
should happen and what actually happens in
practice.1,3
Compared with traditional perioperative care,
the Enhanced Recovery After Surgery (ERAS)
programme represents a fundamental shift in
the process of care, by including multiple inter-
ventions that attenuate surgical stress, maintain
physiological function and expedite return to
baseline.4 While each intervention has a small
effect, all together they have a stronger synergis-
tic impact (Fig. 1).
The ERAS Society recently published three
guidelines on perioperative care focused on
colonic,5 rectal/pelvic6 and pancreatic and gas-
tric resection.7 Previous versions of such guide-
lines have been shown to impact on daily
practice.4,8
Gustafsson and coworkers9 showed that with
better compliance to an evidence-based ERAS
protocol, outcomes improved: ERAS programme
patients treated with less than 50% compliance
had a complication rate of almost 50%, while
those following the protocol more closely (90%
compliance) had fewer than 20% complications.
Similar improvements have been reported in a
meta-analysis of randomised trials.10
The aim of this article was to review the
pathophysiological basis of some key elements
which form the basis of the ERAS programme.
The second article, which follows, is more
hands on and practical, and is meant to propose
recommendations for anaesthetic protocols in
the ERAS setting. Obviously, such an approach
is based on best available evidence and should
not to be seen as set in stone, as there are areas
of challenge for the anaesthesiologist beside
several aspects of controversial nature that
require more research and development. The
current papers are the joint effort of a wide
range of professionals involved in the improve-
ment of perioperative care working for the
ERAS Society.
Methods
The present narrative review has been written
following several meetings of a group of anaes-
thesiologists and surgeons, and after reviewing
the literature between 1990 and 2014 on specific
perioperative topics. The intention of the
authors was to convey concepts of pathophysiol-
ogy within the context of the ERAS programme,
aligning the practice of anaesthesia with the
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care delivered by the surgical team before, dur-
ing and after surgery.
The role of the anaesthesiologist in
implementing ERAS
Implementing ERAS programmes requires a
multidisciplinary approach and within this phi-
losophy, it is vital to avoid a ‘silo mentality’
and this applies most emphatically to the anaes-
thesia member of the team. Indeed in many
institutes/countries, there is a drive towards
anaesthesiologists fulfilling the role of perioper-
ative physicians.
In the pre-operative phase, the anaesthesiolo-
gist may well run a formal pre-admission anaes-
thesia clinic for the assessment of patients
deemed at high risk by either the surgeon or the
pre-admission nurse. Activities may include for-
mal risk assessment, optimisation or referral to
other specialties such as cardiology or the frailty
clinic. In the post-operative phase, the anaesthe-
siologist has a role in patient supervision in
PACU/HDU to optimise opiate sparing, avoid
excessive fluid loading and intervene early with
complications such as delirium. Such a role can
be extended onto the ward as a key member of
the acute pain team. Finally, at a strategic level,
the anaesthesiologist can contribute to team
leadership, protocol compliance, audit and
ongoing team education.
Preparing the patient for surgical stress
The world’s population has increasing longev-
ity, with average life expectancies rising yearly.
A large proportion of the elderly population
requires surgery for various reasons. The physi-
ological changes associated with ageing are
responsible for decreased reserve, impaired
functional status, thus leading to poor capacity
to withstand the stress of surgery. Co-morbidi-
ties associated with the elderly include hyper-
tension, ischaemic heart disease, stroke,
hypercholesterolaemia, chronic obstructive air-
way disease and diabetes. Although age per se
does not preclude surgery, the presence of coex-
isting diseases has a greater impact on post-op-
erative morbidity and mortality than age
alone.11 Furthermore, the burden of obesity,
cancer and surgery represents a major stressor
on organ systems with possible sequelae for
cancer spread and declining functional ability.
Smoking, alcohol, anaemia, poor nutritional sta-
tus and poor glycaemic control can further
impact adversely on post-operative infection
rate, immune function and tissue healing. Pre-
operative anxiety, emotional distress and
Fig. 1. ERAS elements. Reproduced from
Varadhan KK et al. with permission.105
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depression have been shown to be associated
with higher complication rates, greater post-op-
erative pain, cognitive disturbances and delayed
convalescence.
Fitness can be subdivided into coexisting
medical problems and physical fitness. Pre-ex-
isting health factors such as myocardial infarc-
tion, heart failure, stroke, peripheral vascular
disease and impaired kidney function can
increase the risk of post-operative complica-
tions. There is also sufficient evidence that
patients with poor physical conditions and low
anaerobic threshold have greater post-operative
morbidity and mortality.12 In patients with car-
diopulmonary disease, a 6-min walking distance
(6MWD) < 350 m predicts mortality.13 Simi-
larly, in colorectal surgery patients, the 6MWD
(which has a weak inverse correlation with sar-
copenia) was found to correlate well with peak
oxygen consumption in predicting post-opera-
tive cardiopulmonary complications.14
Risk assessment, optimisation of pre-existing
organ function and education are essential
ERAS elements for the preparation of patients
facing surgery. The multidisciplinary team
involved in the process includes anaesthesiolo-
gists, surgeons, internists, nutritionists, physio-
therapists, nurses and, when needed,
psychologists. Besides increasing physiological
reserves and pharmacological optimisation,
patients and caregivers need to be educated
about the surgical process and empowered. The
whole patient journey, starting with evaluation,
then optimisation of physical, mental, nutri-
tional functions (prehabilitation), then moving
through surgery and the hospital episode and
finishing with recovery, should be explained
well in advance to facilitate active participation,
comprehension and allay anxiety. Ideally audio-
visual material should be made available. As
patient expectation plays a role in determining
post-operative outcome, clear information about
the process of care has to be delivered to care-
givers as well as the patients.15
Why it is important to control surgical stress
and maintain homoeostasis
For every action, there is a reaction and the reac-
tion to surgical stress is the metabolic response
to injury. Preventing stress and thus minimising
this response represents the central mechanism
around which the concept of enhanced recovery
is based. This response encompasses all ele-
ments associated with surgery such as anxiety,
fasting, tissue damage, haemorrhage, hypother-
mia, fluid shifts, pain, hypoxia, bed rest, ileus
and cognitive imbalance. Such significant
changes in metabolic and physiological
homoeostasis represent a threat to the body and
mind that need to be treated for a successful
return to pre-operative conditions. Evidence
suggests that this phenomenon, if left untreated,
can lead to increased morbidity and mortality.
Therefore, it makes sense to provide not only a
rational basis for accelerated recovery but also to
minimise the potential risk of organ dysfunction
leading to complications and decreased long-
term survival.16
The “stress response” is represented by hor-
monal and metabolic changes that result in
haematological, immunological and endocrine
responses, and its extent parallels the degree of
tissue injury, being further amplified with post-
operative complications. The interaction
between the endocrine and inflammatory
response is characterised by an elevation in
counter-regulatory hormones (cortisol, growth
hormone, glucagon and catecholamines) induced
by activation of hypothalamic–pituitary–adrenal
axis, and an initial predominance of pro-inflam-
matory cytokines followed by anti-inflammatory
cytokines. Following tissue injury, the systemic
inflammatory response is activated and medi-
ated mainly by pro-inflammatory cytokines such
as interleukins, IL-1 and IL-6. The effects of
these mediators on target organs (such as
hypothalamic thermoregulation or hepatic acute
phase protein production) are modulated poten-
tially by other components of the stress response
(e.g. glucagon, cortisol or adrenaline). Local
change impacts not only on the generalised
inflammatory state but also on homoeostatic,
metabolic and circulatory organs. An example of
surgical stress-induced organ injury is repre-
sented by the occurrence of myocardial injury
after non-cardiac surgery (MINS). MINS is
where myocardial injury occurs causing a raised
peak troponin T level of > 0.03 ng/ml (even
without symptoms or a full definition of
myocardial infarction) and it is an independent
predictor of 30-day mortality.17 In a recent large
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cohort study of over 15,000 patients, 8.0% of
patients suffered MINS with around 58% of
these patients not fulfilling the universal defini-
tion of myocardial infarction and only 15.8% of
patients with MINS experienced an ischaemic
symptom. Although it is not known which
ERAS elements can specifically reduce MINS, it
has been recently demonstrated that when all
the ERAS elements are used cardiovascular
complications are reduced.18
The more extensive the surgical wound, inter-
nal organ manipulation and tissue dissection, the
greater is the stress response. This concept not
only applies to physiological/metabolic changes
but also to changes in the innate immune system.
This combination of catecholamine release and
hyper-inflammation followed by immunosup-
pression can contribute, among other things, to a
state of insulin resistance.19,20
A main reason for the effectiveness of the
ERAS protocols is that many of the different
treatments building the protocol reduce the stress
responses to the injury caused by the operation
and thus help to maintain homoeostasis.
Metabolic homoeostasis
Normal metabolism is governed by anabolic and
catabolic hormones in interplay. Any major
injury including surgery disrupts metabolic
homoeostasis and cause insulin resistance. Insu-
lin resistance can be defined as a condition,
whereby a normal concentration of insulin pro-
duces a subnormal biological response.19 Stud-
ies have demonstrated a significant correlation
between the degree of the patient’s insulin sen-
sitivity on the first post-operative day and
length of hospital stay (r = 0.53, P = 0.0001).20
In a multifactorial analysis, the degree of insulin
resistance, the magnitude of surgery and blood
loss were the three independent factors explain-
ing more than 70% of the variation in length of
stay. More importantly, a significant association
was shown between the magnitude of insulin
resistance and complications. For every decrease
in intraoperative insulin sensitivity by 20%, the
risk of serious complications was more than
doubled after open heart surgery.21
The relevance of insulin resistance to out-
comes is also reflected by the clinical problems
associated with its metabolic sequelae, the cata-
bolic changes in glucose and protein metabo-
lism also known as “diabetes of the injury”. In
non-diabetic patients undergoing major abdomi-
nal procedures, blood glucose (BG) values
> 7 mmol/l are frequently observed. Evidence is
mounting that hyperglycaemia is a predictor of
mortality and complications, and that even a
moderate increase in blood glucose may be asso-
ciated with a worse outcome.22–24 Patients with
fasting blood glucose concentrations > 7 mmol/l
or random blood glucose concentrations
> 11.1 mmol/l on general surgical wards
showed a 18-fold increased in-hospital mortal-
ity, a longer hospital stay and a greater risk of
infection.25 Post-operative protein catabolism is
characterised by a net loss of functional and
structural body protein. Metabolically healthy
patients lose between 40 and 80 g of nitrogen
after elective open abdominal operations, equiv-
alent to 1.2–2.4 kg wet skeletal muscle.26 Also,
protein losses after abdominal surgery are 50%
greater in insulin resistant patients than in those
who are not.27 More recent studies indicate a
linear relationship between insulin sensitivity
and protein balance in parenterally fed patients
undergoing open heart surgery.28 Loss of lean
tissue delays wound healing, compromises
immune function and diminishes muscle
strength. The ensuing muscle weakness inhibits
coughing, impedes mobilisation and prolongs
mechanical ventilation if patients are on inten-
sive care thereby complicating convalescence
and causing morbidity.
Subjects with altered metabolic and inflamma-
tory states such as elderly, diabetics and
patients with cancer undergoing surgery can be
exposed to a greater stress response, profound
catabolic state as result of poor reserve, thus
leading to post-operative complications and
delayed functional recovery.29–31
Plasma glycosylated haemoglobin A (HbA1c)
is an indicator of blood glucose control over the
previous 3–4 months. Observations made in 273
diabetic and non-diabetic patients undergoing
open heart surgery demonstrated a significant
correlation between the quality of pre-operative
glycaemic control as reflected by HbA1c levels
and insulin sensitivity during cardiac surgery
(r = 0.527, P < 0.001).21 In addition, diabetic
patients with HbA1c > 6.5% had a greater
incidence of major complications (P = 0.010),
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and minor infections (P = 0.006). Such patients
received more blood products, and spent
more time in the ICU (P = 0.030) and the
hospital (P < 0.001) than metabolically normal
patients.21 These findings are in agreement with
the results of other observational studies indi-
cating worse outcomes after cardiac, abdominal
and vascular procedures in the presence of
increased HbA1c concentrations.32–34
ERAS interventions reducing insulin
resistance
Several ERAS interventions are directed to
reduce surgical stress and modulate periopera-
tive insulin sensitivity directly and indirectly.
Pre-operative carbohydrate loading and adherence to
pre-operative fasting guidelines
The idea of pre-operative carbohydrate treatment
instead of overnight fasting came from animal
studies showing that coping with stress is much
improved if animals sustain trauma in the fed
rather than fasted state.35 Overnight treatment
with intravenous glucose was shown to attenu-
ate the decrease in muscle insulin sensitivity.36
A similar effect was later shown for oral carbo-
hydrates solutions tailored for pre-operative
use.37 The administration of such pre-operative
oral carbohydrates raises insulin sensitivity by
50%,38 and this carries through to the post-oper-
ative period resulting in 50% less insulin resis-
tance. Carbohydrate loading also shifts cellular
metabolism to a more anabolic state.39 This
allows for better use of any nutritional care
post-operatively, with less risk of hypergly-
caemia and improved retention of protein and
preservation of lean body mass.40 Studies con-
ducted in relatively small patient populations
suggested better outcomes with pre-operative
complex carbohydrates given orally up to 2 h
before anaesthesia and surgery,41,42 However, a
meta-analysis43 and a recent Cochrane analysis44
of all available data from randomised controlled
trials suggest that in major abdominal surgery
there is clinical impact as evidenced by faster
recovery43,44 (reduced length of stay by 1–1.5
days43). However, for minor surgery the benefit
is mainly in patient well-being,41 and in other
types of surgeries the data remain sparse.44
Many National and International Anaesthetic
Societies recommend a 6-h pre-operative fast for
solids and a 2-h fast for clear liquids, including
carbohydrate drinks.44–47
Epidural anaesthesia
Another way of minimising post-operative insu-
lin resistance is to use epidural anaesthesia.
Ample evidence has accumulated in open sur-
gery to identify the peripheral and central ner-
vous system as a common pathway triggering
the catabolic responses to tissue trauma. Block-
ade of these pathways by epidural anaesthesia
and local anaesthetic blocks prevents the
increase in circulating counter-regulatory hor-
mones, thereby minimising insulin resistance
and limiting protein catabolism48 and hypergly-
caemia.49 The physiological effects of epidural
anaesthesia may serve as a rationale for
improved respiratory and cardiovascular out-
comes after general, urological and vascular pro-
cedures as reported by meta-analyses and
randomised controlled trials.50,51
Early post-operative feeding
A further additional potentially beneficial way
to maintain metabolic homoeostasis is early
feeding. Early recommencement of post-opera-
tive nutrition has been shown to benefit the
patient.52 However, most of the available data
are from patients undergoing surgery in a tradi-
tional care programme, and very little is known
about the effects of nutrition in a modern ERAS
programme. One small study showed that after
major colorectal surgery, in patients given pre-
operative carbohydrates and thoracic epidural
anaesthesia, complete enteral feeding initiated
immediately after the operation normalised glu-
cose levels and was associated with abolition of
the catabolic response to surgery such that there
was no net loss of body nitrogen (protein).53
This suggests that it is possible to overcome
most of the metabolic response to injury when
post-operative feeding is combined with pre-op-
erative carbohydrates and epidural anaesthesia.
Glycaemic control
The therapeutic administration of insulin is an
obvious choice to overcome perioperative
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insulin resistance and improve outcome. Normo-
glycaemia and whole body protein stores can be
preserved by insulin therapy suggesting that
insulin sensitivity rather than insulin respon-
siveness is reduced during and after surgery.54
Although the safety and efficacy of glucose con-
trol in the ICU has been debated, trials have
consistently shown that in post-operative
patients55 and in trauma patients56 improved
glucose control with insulin in the intensive
care situation has proven beneficial by avoiding
complications as long as the deleterious effects
of hypoglycaemia are avoided. In the ward situ-
ation, intensive insulin treatment is more dubi-
ous and hard to control and, therefore, measures
should be taken to minimise the insulin resis-
tance and thereby avoiding the need of insu-
lin.53
Magnitude of surgery and homoeostasis
Minimising the total surgical injury is the prin-
cipal aim of minimally invasive surgery (MIS),
and with optimal surgical techniques the bene-
fits are not just from the reduction in wound
size. This concept can be categorised into pri-
mary and secondary injury due to surgery. The
primary injury is direct trauma to the abdominal
wall or tissue damage from mobilisation of tis-
sues or trauma to organs themselves. There is
also indirect injury during surgery from bleed-
ing or the physiological effects from anaesthetic
techniques (intermittent positive pressure venti-
lation, drugs causing local vasomotor changes
causing local blood flow changes) and the phys-
iological effects of patient positioning combined
with the abdominal pressure of the CO2 pneu-
moperitoneum. The rationale behind minimis-
ing the access wound in particular is to reduce
the activation of neuro-humoral pathways that
affect recovery adversely. Reducing neuro-hu-
moral stimulation may be achieved by reducing
access trauma and internal trauma associated
with the surgery.
Trauma to the abdominal wall may be
reduced by changing the orientation of the inci-
sion such that it traverses fewer myotomes and
dermatomes. Where open surgery is performed,
transverse incisions may reduce post-operative
pain and improve outcomes but the evidence for
this is not clear.57–59 The length of the access
incision can be reduced using laparoscopic tech-
niques that will reduce both the total additive
length of the incisions and the maximum length
of any one incision. Additionally, modern ports
used for access work by splitting muscle fibres
rather than dividing them, which is also less
traumatic.
The intra-abdominal part of the operation is
usually similar whether performed with open
access or laparoscopically, but differs in a num-
ber of ways which might reduce trauma. This is
witnessed by good evidence that overall blood
loss is less60 and adhesions are reduced follow-
ing laparoscopic colorectal surgery.61 A number
of factors may contribute but the reduction of
the size of peritoneal injury, the reduced serosal
injury and the reduced blood loss will all
reduce the tendency to form adhesions. The use
of modern energy sources such as ultrasonic
technology may also be a factor both in reducing
blood loss but also reducing the collateral dam-
age associated with other techniques. The tech-
niques that have been developed with
laparoscopic surgery also dictate the necessity to
dissect carefully within bloodless plains where
possible which may have a benefit in reducing
collateral injury and reducing stimulation. This
results in a reduction in secondary injury reduc-
ing the cytokine, hormonal and neural
responses to surgery. The benefits of MIS are
further enhanced by reducing consequential
problems from fasting and immobilisation as
there is a more rapid return of gut function and
improved mobilisation.
The benefits from using MIS has to be bal-
anced against the fact that to perform MIS the
carbon dioxide (CO2) pneumoperitoneum and
patient position may have detrimental physio-
logical effects which can be compounded if the
duration of surgery is long. The initiation of
CO2 pneumoperitoneum triggers a sympathetic
response and major changes in blood flow and
respiratory mechanics. In fluid optimised
patients, there is a rise in aortic afterload with
resulting decrease in stroke volume and resul-
tant reduction in oxygen delivery which can
affect outcome.62 This response usually lasts for
20–25 min until adaptation occurs but in some
patients cardiac output remains low.55 Studies
to look at reducing the physiological impact of
CO2 pneumoperitoneum by using special ports
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or deep neuromuscular block to facilitate good
surgical exposure at lower pressures are ongo-
ing.
Such graded interaction between minimal
access surgery and ERAS is reflected in an addi-
tive effect in reduction of length of stay.63 Thus
MIS with its reduction in both primary and sec-
ondary injury has become a major component of
ERAS.
Surgery and fluid balance
Following the initiation of injury, the release of
catabolic hormones and inflammatory mediators
facilitate salt and water retention to preserve
intravascular volume, maintain blood pressure
and vasoconstriction, and provide gluconeogenic
substrates for metabolism and cell function.
Body temperature decreases to minimise oxygen
utilisation, and blood is shunted away from
“non-vital” organs such as the gut, skin and
muscle to maintain perfusion in vital organs like
the heart, brain and kidney. Gene and protein
expression of mediators of inflammation and
insulin resistance, such as IL-6, AKT-1, FOXO-
1, and PDK4 are increased within hours of the
incision at the site of the injury (rectus abdo-
minis muscle) and, to a lesser extent, distant
from the site of the injury (vastus lateralis mus-
cle).64 There is also a consistent suppression of
muscle mitochondrial complex activity and a
decrease in ATP production rates over the same
time period.65 These changes are associated with
an increase in intestinal permeability. Blood
rheology is also altered with the initiation of a
hypercoagulable state.
Teleologically, mammals have developed very
efficient mechanisms to conserve salt and water
in the face of fluctuations in water supply, scar-
city of salt and reductions in plasma volume.
On the other hand humans have not, until
recent times, been exposed to salt excess and
our mechanism for excreting this is correspond-
ingly inefficient, depending on a slow and sus-
tained suppression of the renin–angiotensin–
aldosterone axis.66,67
Salt and water overload has been shown to
impact on anastomotic integrity. Furthermore,
ileus and increasing post-operative complica-
tions leading to prolonged hospital stay have
been reported when maintenance of patients in
a state of near-zero fluid balance is not
achieved.66,68 Generally, it has been shown that
post-operative complications are increased when
the weight gain in the post-operative period
exceeds 2.5 kg (indicative of a 2.5 l cumulative
fluid overload).69
The maintenance of fluid and electrolyte bal-
ance and tissue perfusion is achieved directly
with several modalities within the ERAS pro-
gramme and indirectly by overall modulation of
the hormonal and inflammatory response. The
principle of maintaining a patient in the zone of
normovolaemia is to maintain a normal intravas-
cular volume and avoid gaining weight due to
excessive administration of fluid. Adequate pre-
operative hydration and avoidance of bowel
preparation aim to keep the patient close to nor-
movolaemia prior to surgery. Physiological
interventions during anaesthesia such as inter-
mittent positive pressure ventilation, vasoactive
drugs and regional anaesthetic techniques can
all affect vasomotor tone and intravascular vol-
ume. Due to the venous capacitance vessels,
there is a range (sweet spot) within which nor-
movolaemia, cardiac output and tissue perfusion
can be adequately maintained. The experienced
anaesthesiologist can keep the patient in this
zone of normovolaemia throughout the operative
and immediate post-operative periods. The use
of additional monitoring devices such as pulse
pressure variation (PPV), stroke volume varia-
tion (SVV), oesophageal Doppler and pulse con-
tour wave analysis can all provide the
anaesthesiologist with additional useful infor-
mation to help guide fluid therapy, even though
routine use of advanced hemodynamic monitor-
ing and cardiac output optimisation has not
shown to consistently improve post-operative
outcomes.70–73 This is more important when the
physiological situation is challenging such as
haemorrhage, poor cardiac function or vasodi-
latation secondary to drugs, regional analgesia
or sepsis. Optimal control of intravascular vol-
ume, cardiac output and oxygen delivery com-
bined with perfusion pressure maintains
optimal oxygen and nutrient delivery to the
cells as well as reducing extracellular fluid flux.
Maintenance of normothermia maintains central
and peripheral perfusion and effective circula-
tory volume. This makes it easier for the anaes-
thesiologist to avoid the patient becoming
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relatively hypovolaemic with resultant hypoper-
fusion of tissues with development of acidosis
and lactataemia. The early establishment of oral
intake of fluids as soon as possible after surgery
allows the body to control homoeostasis.
Figure 2 shows 2 patient pathways with fluid
shifts during and immediately after surgery. One
patient is in an ERAS surgical protocol and the
other in a traditional surgical pathway. The
patient undergoing surgery within a traditional
pathway has prolonged starvation and bowel
preparation causing dehydration. The patient is
hypovolaemic prior to the start of surgery and at
the start anaesthesia, and intermittent positive
pressure ventilation and drugs have a further
negative effect causing splanchnic hypoperfu-
sion. Intravenous fluid infusion restores the
intravascular volume, however the prolonged
continuation of intravenous fluids post-opera-
tively for several days can lead to relative hyper-
volaemia and gut oedema with resultant ileus.
The patient within the ERAS programme starts
surgery within the ‘green zone’ of normo-
volaemia and is maintained there by the anaes-
thesiologist monitoring stroke volume and keep
intravascular volume optimised which in turn
reduces fluid shifts. Intravenous fluids are main-
tained at appropriate rates in the immediate
post-operative period to maintain normo-
volaemia, but are then stopped with the com-
mencement of oral intake thus avoiding salt and
water overload. It is obvious that the controversy
on perioperative fluid balance will continue as
more research is carried out in patients at risk
where careful administration of fluids and
appropriate monitoring are taken into account.
Surgery and gut dysfunction
Major abdominal surgery induces an immuno-
inflammatory response, which is accompanied
by the production of reactive oxygen species
(ROS) at the site of injury causing direct cellular
injury by damaging lipids, proteins and DNA.
Similarly, the hypothalamic peptide corti-
cotropin-releasing hormone appears to interact
with the inflammatory components and inhibit
bowel function. The resulting impaired vascular
permeability together with excessive fluid
administration can lead to fluid overload, inter-
stitial oedema and therefore delayed recovery of
gastrointestinal function and impaired anasto-
motic healing.68
The causation of post-operative ileus is multi-
factorial and a number of risk factors have been
identified (Fig. 3). These include increasing age,
male gender, low pre-operative serum albumin,
acute and chronic opioid use, previous abdominal
surgery, pre-existing airways and vascular dis-
ease, long duration of surgery, emergency surgery,
blood loss and salt and water overload. Most of
these factors increase the inflammatory response,
and inflammation and oedema play a major role
in reducing intestinal smooth muscle contractil-
ity.74 ERAS principles are aimed at reducing peri-
operative stress and inflammation and, hence, can
reduce the duration of ileus and accelerate recov-
ery of gut function post-operatively.
A number of strategies have been suggested
to prevent post-operative ileus and some are
more effective than others. These have been
reviewed extensively recently and are sum-
marised in Table 1.74
Fig. 2. Perioperative fluid administration
with and without an ERAS surgical pathway:
risk of perioperative fluid excess and tissue
hypoperfusion.104 Reproduced from Minto G
et al. with permission.
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Alvimopan is a peripherally acting l-opioid
receptor antagonist, which does not cross the
blood–brain barrier readily. A meta-analysis
examining the effect of alvimopan vs. placebo
on POI after major abdominal surgery found
that alvimopan accelerated recovery of gastroin-
testinal function by 1.3–1.5 days at a dose of
12 mg/day and 6 mg/day respectively.75 The
time to readiness for discharge was also reduced
correspondingly.75 However, alvimopan is
expensive ($1000 for 15 doses) and is not read-
ily available outside the United States.
Surgery and anaesthesia are responsible for
initiating nausea and vomiting in the post-oper-
ative period. More specifically, abdominal dis-
tension, bowel manipulation, intracellular fluid
overload, and opioids stimulate peripherally
(gut) and centrally located receptors that activate
the central coordinating site for nausea and
vomiting which is located in an ill-defined area
of the lateral reticular formation in the brain
stem.76,77 This “vomiting centre”, as it is tradi-
tionally called, is not so much a discrete centre
of emetic activity as it is a “central pattern gen-
erator” (CPG) that sets off a specific sequence of
neuronal activities throughout the medulla to
result in vomiting.78–80 A particularly important
afferent is the chemoreceptor trigger zone (CTZ),
which is located at the base of the fourth
ventricle in the area postrema, outside the
blood–brain barrier, and plays a role in detect-
ing emetogenic agents in the blood and
cerebrospinal fluid (CSF).78 Five distinct recep-
tor mechanisms have been identified in the CTZ
that are involved in nausea and vomiting. They
are serotonergic, dopaminergic, histaminergic,
muscarinic and neurokinin-1 type. A variety of
different pharmacological agents, acting on one
Fig. 3. Pathogenesis of post-operative ileus. MLC, myosin light chain; STAT, signal transducer and activator of transcription; TNF, tumour necrosis
factor; VIP, vasoactive intestinal polypeptide. From Bragg et al. with permission.74
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or more of the five major neurotransmitter cate-
gories are routinely used for the prophylaxis
and/or treatment of PONV.81
Opioids, although not neurotransmitters, may
have a significant effect on PONV, exerting both
excitatory and inhibitory effects on the gastroin-
testinal system (e.g. inhibition of gastrointesti-
nal motility). There are at least three different
types of opioid receptors – l, d and k. Exoge-
nous opioid receptor agonists (e.g. morphine)
affect intestinal motility by modulating cholin-
ergic transmission. When administered periph-
erally, exogenous opioid receptor agonists
decrease gastrointestinal motility and delay gas-
tric emptying by inhibiting central l-recep-
tors.82
Risk factors for PONV are based on character-
istics relating to the patients, anaesthetic or type
of surgery. Specific risk factors for PONV in
adults are female gender, history of PONV or
motion sickness, use of opioids and non-smok-
ing status. Although the relationship between
patient-related risk factors and PONV are clear
and well studied, such a relationship with type
and duration of surgery is less clear. Neverthe-
less, a simplified risk scoring system for PONV
incorporating the four risk factors have good
predictability and is recommended for risk-
based PONV prophylactic therapy.81
Surgery and nociception
Surgical incision and manipulation of tissues
lead to cell disruption releasing a variety of
intracellular chemical mediators. These include
potassium, adenosine, prostanoids, bradykinin,
nerve growth factors, cytokine and chemokine
which activate and sensitise (peripheral sensi-
tisation) peripheral nociceptors Ad and c-fibres
to mechanical stimuli (primary hyperalgesia).
These pro-inflammatory substances and the
release of substance P and calcitonin gene-
related peptide from the peripheral branches of
nociceptors also sensitise silent Ad nociceptors
in the adjacent non-injured tissues (secondary
hyperalgesia). Repeated and prolonged stimula-
tion of peripheral nociceptors in the injured
area and in the surrounding non-injured tissues
lead to an increase firing of neurons at the
level of the dorsal horn of the spinal cord, medi-
ated by the activation of Na-methyl-D-aspartate
(NMDA) receptors (central sensitisation). Clini-
cally, these pathophysiological changes could
manifest with hyperalgesia, allodynia, and even
persistent postsurgical pain. Descending sympa-
thetic inhibitory pathways also play an impor-
tant role at the level of the spinal cord by
modulating transmission of noxious inputs. The
response to nociception contributes to activate
and potentiate the stress response associated
with surgery. Activation of the hypothalamic–
pituitary–adrenal axis (HPA), sympathetic stim-
ulation and systemic release of pro-inflammatory
cytokines are major determinants of post-opera-
tive insulin resistance, that if not attenuated
potentially lead to multiorgan dysfunction
(Fig. 4). Acute surgical pain can, therefore, be
Table 1 Strategies to prevent post-operative ileus. From Bragg
et al.74 with permission.
Intervention Mechanism Benefit
++
Salt and fluid
overload
↓ gut oedema and stretch 
Carbohydrate
loading
↓ insulin resistance 
Routine
nasogastric
tubes
Prophylactic drainage of stomach +
Intravenous
lidocaine
Anti-inflammatory; opioid-sparing +
Coffee Stimulatory effect +
Chewing gum Stimulatory effect ++
NSAIDs Anti-inflammatory; opioid-sparing ++
Early enteral
nutrition
Anabolic; ↓ insulin resistance;
stimulatory
++
ERPs Multimodal effect ++
Laparoscopic
surgery
↓ tissue trauma; ↓ bowel
handling; ↓ inflammatory
reaction
++
Alvimopan l-opioid receptor antagonist ++
Mid-thoracic
epidural
anaesthesia
↓ inflammatory response
↓ sympathetic stimulation
↓ opioid requirement +/
Early mobilisation ? anabolic effect +
Nicotine Colonic prokinetic +
Daikenchuto Anti-inflammatory on
acetylcholine receptors
+
Magnesium
sulphate
Anaesthetic effect 
Prokinetics Prokinetic effect
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somatic, visceral or neuropathic depending on
the type of surgery and on the surgical
approach.83,84 The scientific rationale for multi-
modal analgesia is based on the multifactorial
nature and complexity of surgical pain path-
ways. The purpose of multimodal analgesia is to
control pain with different classes of medica-
tions acting on multiple sites.85 In the context of
the ERAS programme, the adaptation of multi-
modal analgesic strategies aims not only to
improve post-operative pain control and reduce
surgical stress but also to attenuate the multior-
gan dysfunction induced by unrelieved pain,
reduce opioid side effects, facilitate early
resumption of oral diet and early mobilisation
and ultimately accelerate surgical recovery
(Fig. 4). Ten years ago ERAS programmes relied
extensively on thoracic epidurals and NSAIDs
as the cornerstones of analgesia. For colorectal
surgery at least, there has been a sea change
away from open surgery and towards laparo-
scopic techniques whenever possible. Equally,
there have been concerns raised about a possi-
ble adverse influence of NSAIDs on anastomotic
integrity.86 These two factors have led to the
increased use of spinals/TAP blocks or intra-
venous lidocaine and decreased use of epidural
anaesthesia/NSAIDs.87,88 It has to be said that
while the physiological effects of epidural
blockade on surgical stress have been well vali-
dated, the same cannot be said for lidocaine i.v.
infusion and local anaesthetics techniques such
as TAP blocks.
Surgery and cognitive dysfunction
Surgical trauma provokes a neuroinflammatory
response resulting in either transitory and rever-
Fig. 4. Post-operative pain: physiological consequences and impact on outcomes and ERAS protocol. CNS, Central Nervous System; HPA axis,
Hypothalamic–Pituitary–Adrenal axis; CV, Cardiovascular; HR, Heart Rate; SVR, Systemic Vascular Resistance; MRO2, Metabolic Rate of Oxygen;
FRC, Functional Residual Capacity; VC, Vital Capacity; MV, Minute Ventilation; GI, Gastrointestinal; ADH, Antidiuretic Hormone; PG, Prostaglandins;
UO, Urinary Output; UR, Urinary Retention; VTE, Venous Thromboembolism; IR, Insulin Resistance. Reproduced from Cologne K et al. with
permission.106
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sible or persistent impairment of cognition.89
While some patients develop post-operative
delirium (POD), characterised by inattention,
disorganised thinking and altered level of con-
sciousness, others develop post-operative cogni-
tive dysfunction (POCD) which is chronic by
nature and characterised by deficit in attention,
concentration, executive function, verbal mem-
ory, visuospatial abstraction and psychomotor
speed.
The international study on post-operative
cognitive dysfunction (ISPOCD 1) study pub-
lished in the lancet in 1998 demonstrated
long-term POCD in elderly patients undergo-
ing non-cardiac surgery.90 However, the second
study published in 2003 (ISPOD2) found no
significant difference in the incidence of cogni-
tive dysfunction 3 months after either general
or regional anaesthesia.91 Accordingly, there is
no evidence to suggest any causative rela-
tionship between general anaesthesia and
long-term POCD.
A possible pathogenic mechanism is of
inflammatory nature whereby pro-inflammatory
cytokines increased significantly in the systemic
circulation and the central nervous system.92
Pre-existing factors can contribute to POCD,
such as advanced age, metabolic syndrome, edu-
cation, vascular dementia and attention deficit
disorders. Sleep disruption, poor analgesia,
anaesthetic medications such as benzodiazepines
can further exacerbate POCD.
Due to the complexity of the pathogenic
mechanism and the multifactorial nature of POD
and POCD, attempts are made to identify vul-
nerable patients and interventions which pro-
mote resolution of neuroinflammation. In this
context, strategies such as minimally invasive
surgery, guiding anaesthetic depth with BIS
monitoring,93,94 adequate pain relief, limited
use of benzodiazepines95,96 and opioids, a quiet
environment to facilitate sleep and accelerated
discharge home have been proposed as effective
measures which need to be confirmed in large
trials.
Surgery and post-operative deconditioning
Prolonged bed rest for up to several weeks in
hospital was standard surgical practice until the
1940s, probably originating from fears of wound
infection or dehiscence and the idea that rest
would promote tissue healing.97 Individuals
confined to bed experience a linear decline in
exercise capacity, as a result of reduced maximal
stroke volume and cardiac output with VO2max
decreasing at a rate of about 1% every 2 days.98
Complications of prolonged bed rest include
skeletal muscle atrophy and weakness, bone
loss, decreased insulin sensitivity, thromboem-
bolic disease, microvascular dysfunction, atelec-
tasis and pressure ulcers.99,100 The negative
effects of bed rest can occur after a relatively
short period. Decreases in insulin sensitivity can
also be detected after as little as 3 days of bed
rest; even just 1 day of physical inactivity (sit-
ting) can reduce insulin sensitivity signifi-
cantly.101 In older patients, deconditioning
occurs by day 2 of hospitalisation.102
Post-operative fatigue (POF) is a well-recog-
nised condition characterised by tiredness, lack
of concentration which can impact on patient’s
quality of life. It can occur for several weeks
after abdominal surgery and the duration is
related to the intensity of surgery.103 It appears
that cancer has some influence on the develop-
ment of post-operative fatigue. Beside the
reported unpleasant and distressing symptoms,
objective measures of POF have been identified,
such as increased exercise-induced heart rate,
elevated production of pro-inflammatory cytoki-
nes, decline in cardiorespiratory effort, weight
loss, muscle weakness and anorexia. Patients
need more energy to perform a given physical
task. The psychological aspects of POF have
been studied in depth, and it appears that while
early symptoms of fatigue can be due to somati-
sation, late fatigue is secondary to cognitive-be-
havioural factors. Pre-operative anxiety and
depression has been reported to be predictive of
the development of fatigue.
ERAS pathways are not specific in relation to
the type of exercise to be conducted after sur-
gery as there is no evidence at present to sup-
port the use of one plan over another. There is a
need to emphasise the importance of an early
structured mobilisation plan with daily written
targets for time out of bed or distance walked,
beginning as early as the day of surgery. POF
has a multimodal aetiology and, therefore,
requires multimodal intervention. Some impro-
vement in POF has been reported with imple-
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mentation of combining therapeutic strategies,
however more data are required.
Conclusions
Understanding the pathophysiology of the surgi-
cal stress response enables clinicians to identify
the therapeutic interventions which are incorpo-
rated into the ERAS pathway aiming at acceler-
ating the recovery process by targeting some key
elements, insulin resistance, disruption of
homoeostasis and nociceptive stimulation. There
is some evidence that the ERAS synergistic
approach is effective and physiologically makes
sense, although this is not always translated
into clinical outcome. Many aspects need more
clarification as the literature is conflicting as
ERAS principles continue to evolve and more
research is required. ERAS is evidence-based,
however translation into clinical care is lagging.
It requires continuing professional development,
additional debate, interdisciplinary involve-
ment, patient education and regular revalida-
tion. Ultimately, ERAS can lead to major
improvements in the quality of patient care, bet-
ter patient outcomes as well as economic bene-
fits for the whole health care system. This
implies that anaesthesiologists play a cru-
cial role in development and the deployment of
the programme.
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